Childrens Allegra Hives (fexofenadine hcl) NDC 41167-4227

NDC codes

FDA NDC Directory

Product NDC (as listed)41167-4227Labeler and product segments. Claims need a package NDC.

Product NDC at billing width41167-4227Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
41167-4227-1	41167422701	1 BOTTLE, PLASTIC in 1 CARTON (41167-4227-1) / 240 mL in 1 BOTTLE, PLASTICMarketed from May 1, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Childrens Allegra Hives
Generic name (nonproprietary): fexofenadine hcl
Active ingredients: Fexofenadine hydrochloride — 30 mg/5mL
Dosage form: Suspension
Route: Oral
Labeler: Chattem, Inc.
Product type: Over-the-counter drug
Marketing category: NDA — New Drug ApplicationApplication NDA 201373
Marketing start: May 1, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Histamine H1 Receptor Antagonists (Mechanism)
Identifiers: Product ID 41167-4227_37df2ad5-479f-4534-b550-e42479a3b2dbSPL ID 37df2ad5-479f-4534-b550-e42479a3b2dbSPL set ID ff50d9cd-d849-43e8-b32a-4dcde798d3ebRxCUI 997491UNII 2S068B75ZU
Pharmacologic class: Histamine-1 Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N441167422701 followed by a unit qualifier and the quantity

Package 41167-4227-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 1, 2026.

Indications (excerpt from the label)

Uses reduces hives and relieves itching due to hives (urticaria). This product will not prevent hives or an allergic skin reaction from occurring.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 201373

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 201373
Product	Strength	Form · route	Labeler	Product NDC
Childrens Allegra Allergyfexofenadine hydrochloride	Fexofenadine hydrochloride 30 mg/5mL	SuspensionOral	Chattem, Inc.	41167-4244
Childrens Allegra Allergyfexofenadine hydrochloride	Fexofenadine hydrochloride 30 mg/5mL	SuspensionOral	Chattem, Inc.	41167-4246